Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Bodey

Showing results (571-580 of 726) with videos related to

Pageof 73
Sort By:
Cancer Treatment Reports|March 1, 1981
Phase II evaluation of AMSA in adult sarcomasB S Yap, C Plager, R S Benjamin, et al.
Seminars in Oncology|September 1, 1976
Neoplasia, kinetics, nd chemotherapyJ S Hart, R B Livingston, W K Murphy, et al.
Cancer|April 1, 1977
Prognotic significance of pretreatment proliferative activity in adult acute leukemiaJ S Hart, S L George, E Frei, et al.
Cancer Treatment Reports|December 1, 1982
Doxorubicin-DNA complex: a phase I clinical trialS W Hall, R S Benjamin, M A Burgess, et al.
American Journal of Clinical Oncology|October 1, 1982
Combination chemotherapy with continuous infusion vinblastine and peptichemio for patients with advanced metastatic breast cancerH Y Yap, G R Blumenschein, G N Hortobagyi, et al.
Cancer|June 15, 1981
A phase II evaluation of methyl CCNU and actinomycin D in the treatment of advanced sarcomas in adultsB S Yap, R S Benjamin, M A Burgess, et al.
Cancer Research|March 1, 1983
Bisantrene, an active new drug in the treatment of metastatic breast cancerH Y Yap, B S Yap, G R Blumenschein, et al.
Cancer|August 1, 1975
COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumorsR B Livingston, L H Einhorn, G P Bodey, et al.
Annals of Internal Medicine|July 1, 1980
4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemiaS S Legha, M J Keating, A R Zander, et al.
Blood|March 1, 1977
Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphomaV Rodriguez, F Cabanillas, M A Burgess, et al.
Pageof 73

Showing results (571-580 of 726) with videos related to

Sort By:
Pageof 73
Cancer Treatment Reports|March 1, 1981
Phase II evaluation of AMSA in adult sarcomasB S Yap, C Plager, R S Benjamin, et al.
Seminars in Oncology|September 1, 1976
Neoplasia, kinetics, nd chemotherapyJ S Hart, R B Livingston, W K Murphy, et al.
Cancer|April 1, 1977
Prognotic significance of pretreatment proliferative activity in adult acute leukemiaJ S Hart, S L George, E Frei, et al.
Cancer Treatment Reports|December 1, 1982
Doxorubicin-DNA complex: a phase I clinical trialS W Hall, R S Benjamin, M A Burgess, et al.
American Journal of Clinical Oncology|October 1, 1982
Combination chemotherapy with continuous infusion vinblastine and peptichemio for patients with advanced metastatic breast cancerH Y Yap, G R Blumenschein, G N Hortobagyi, et al.
Cancer|June 15, 1981
A phase II evaluation of methyl CCNU and actinomycin D in the treatment of advanced sarcomas in adultsB S Yap, R S Benjamin, M A Burgess, et al.
Cancer Research|March 1, 1983
Bisantrene, an active new drug in the treatment of metastatic breast cancerH Y Yap, B S Yap, G R Blumenschein, et al.
Cancer|August 1, 1975
COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumorsR B Livingston, L H Einhorn, G P Bodey, et al.
Annals of Internal Medicine|July 1, 1980
4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemiaS S Legha, M J Keating, A R Zander, et al.
Blood|March 1, 1977
Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphomaV Rodriguez, F Cabanillas, M A Burgess, et al.
Pageof 73